What is BioStep?
BioStep operates as a specialized laboratory dedicated to the fabrication of custom foot orthotics, diabetic inserts, and advanced ankle-foot orthoses (AFOs). By integrating meticulous craftsmanship with clinical requirements, the company addresses the complex needs of patients requiring tailored foot care solutions. Their market position is defined by a commitment to high-quality, patient-centric manufacturing, serving as a critical link in the healthcare supply chain for individuals with mobility and structural foot challenges. The firm's ability to produce partial foot prosthetics further distinguishes its technical capabilities in a competitive landscape.
How much funding has BioStep raised?
BioStep has raised a total of $113K across 1 funding round:
Debt
$113K
Debt (2021): $113K with participation from PPP
Key Investors in BioStep
PPP
Public-Private Partnership
What's next for BioStep?
Following this late-stage financing, BioStep is positioned to accelerate its operational capacity and potentially broaden its distribution network. The strategic allocation of this capital will likely focus on enhancing production efficiency and investing in advanced fabrication technologies to meet the rising demand for personalized medical devices. As the company transitions into this next phase of growth, the focus will remain on maintaining the high standards of its handcrafted product lines while scaling to accommodate a larger patient base. This infusion of resources provides the necessary runway to explore new market segments and strengthen the company's competitive moat in the orthotics industry.
See full BioStep company page
